NeoGenomics, Inc. NEO

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 38.9% gain over the past six months, beating the S&P 500 by 20.9 percentage points.

What a time it’s been for NeoGenomics. In the past six months alone, the company’s stock price has increased by a massive 138%, reaching $19.30 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

NeoGenomics stock reaction to precision oncology expansion plan NeoGenomics (NEO) drew investor attention after executives detailed plans to expand in community-based precision oncology, highlighting next-generation sequencing, minimal residual disease testing, and workflow tools for community physicians as key focus areas. NeoGenomics shares have been on a strong run recently, with a 30-day share price return of 14.31% and a 90-day gain of 69.22%. The 1-year total shareholder return of...

Earlier in 2026, NeoGenomics executives detailed plans to expand in community-based precision oncology, with a particular push into next-generation sequencing, minimal residual disease testing, and workflow tools for community oncologists. An important takeaway is that NGS already represents a relatively small share of test volume but a much larger portion of clinical revenue, underscoring how mix shift toward advanced assays could reshape the company’s earnings profile. We’ll now examine...

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at NeoGenomics (NASDAQ:NEO) and its peers.

VANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) -- AnorTech Inc. (“AnorTech” or the “Company”) (TSX Venture Exchange “ANOR”; OTCQB “ANORF”) is pleased to announce that, the Company has received cash and shares following the closing of Greenland Mines Ltd.’s acquisition of the Sarfartoq rare earth element (“REE”) project in Greenland from Neo Performance Materials Inc. Under the terms of AnorTech’s agreement with Neo (see NR2026-02), the Company was entitled to receive 5% of the tota

Neo Performance Materials announced that it entered into a binding term sheet with France’s Carester SAS to secure heavy rare earth supply, expand recycling of magnet scrap, and toll-process mixed rare earth carbonate in Europe, supporting its upcoming European sintered magnet facility that is planned to start commercial production in the second half of 2026. This partnership effectively tightens Neo’s European rare earth magnetics loop by combining secure heavy rare earth inputs,...

Neo Performance Materials (TSX:NEO) has entered a new partnership with French rare earth technology company Carester SAS to support its European rare earth magnetics supply chain. The agreement covers long-term access to heavy rare earth materials, recycling of magnet production scrap and toll processing at Neo's Silmet facility in Europe. The partnership is intended to strengthen Neo's position in the European rare earth market and support regional supply chain resilience. This move...

Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) (OTCQX: NOPMF) today announced the closing of the previously announced transaction under which its wholly-owned subsidiary, Neo North Star Holdings LLC ("NNSH"), together with the other shareholders of NNSR Holdings Inc. ("NNSR Holdings"), transferred all outstanding shares of NNSR Holdings and Neo North Star Resources, Inc., a wholly owned subsidiary of NNSR Holdings, via merger of NNSR Holdings to Greenland Mines Ltd. ("Greenla

FORT MYERS, Fla., September 01, 2026--NeoGenomics will participate in the Morgan Stanley 24th Annual Global Healthcare Conference, Sept. 14–16, 2026, in New York.

Neo Performance Materials Inc. ("Neo") (TSX: NEO) (OTCQX: NOPMF) today announced that it has entered into a binding term sheet with Carester SAS ("Carester"), a French rare earth technology company currently building a recycling and heavy rare earth separation facility, Caremag, in Lacq, France, creating a strategic partnership to further advance Neo's strategy of strengthening its rare earth magnetics supply chain across Europe. The partnership is expected to secure Neo's access to Carester's s